National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 5/7/2021 release of VAERS data (an older release, current is 1/14/2022):

This is VAERS ID 1272105

Government Disclaimer on use of this data

Case Details

VAERS ID: 1272105 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Female  
Location: California  
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Private       Purchased by: ?
Symptoms: CSF protein normal, Guillain-Barre syndrome, Immunoglobulin therapy, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Trazodone, Alprazolam, Percocet
Current Illness:
Preexisting Conditions: CHF, Restrictive lung disease, depression, chronic pain, gastroparesis, interstitial cystitis, chronic headaches.
Allergies: Zyprexa, Elavil, DHE, Imitrex, Talwin, Nubain, Xyrem, Lexapro, mirtazapine, stadol, sulfa, prochloperazine, sumatriptan, metoclopramide, sodium oxybate, meperidine, morphine
Diagnostic Lab Data: CSF negative for protein elevation.
CDC Split Type:

Write-up: Guillain Barre Syndrome. Leg weakness one week following vaccine. Hospitalized. Treated with IVIG. Improved with leg weakness only sequela.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166